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Abstract
Objectives: Photodynamic therapy (PDT) is an effective cancer treatment that uses
photosensitizers, light, and oxygen to destroy malignant cells. Porphyrins, and in particular the
cationic derivatives, are the most investigated photosensitizers for PDT. In this context, it is
important to study new methodologies to develop efficient cationic photosensitizers for use in
PDT.
Materials and Methods: New porphyrins bearing cationic epoxymethylaryl groups were
synthesized and characterized. Their cellular uptake, intracellular localization, and phototoxicity
were evaluated in human HEp2 cells, and compared with their methylated analogs.
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Results: All cationic porphyrins were efficient generators of singlet oxygen, with quantum yields
in the range 0.35–0.61. The two methylated derivatives (3 and 4) accumulated the most within
cells at all times investigated, up to 24 hours. Of these two porphyrins, 4 was the most phototoxic
to the cells (LD50 = 2.4 μM at 1.5 J/cm2); however, porphyrin 3 also showed high phototoxicity
(LD50 = 7.4 μM at 1.5 J/cm2). The epoxymethyl-containing porphyrins were found to be less
phototoxic than the methylated derivatives, with LD50>38 μM. The neutral porphyrins showed no
phototoxicity up to the 100 μM concentrations investigated, and had the lowest singlet oxygen
quantum yields. All cationic porphyrins localized mainly in the cell ER, Golgi apparatus, and
lysosomes.
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Conclusion: Our results suggest that cationic methylated porphyrin derivatives are promising
PDT photosensitizing agents. The epoxymethyl-containing derivatives showed increased efficacy
relative to the neutral analogs, and are good candidates for further investigation. Lasers Surg. Med.
50:566–575, 2018.
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INTRODUCTION
Photodynamic Therapy (PDT) has several advantages over other cancer treatments, such as
surgery and radiation therapy, because it is relatively non-invasive; PDT is also considered to
be a localized form of therapy due to the tendency of the photosensitizers to accumulate in
cancer tissues, combined with controlled light delivery at a specific wavelength. The
photosensitizer-accumulated malignant cells are then destroyed via necrosis and/or apoptosis
due the action of singlet oxygen, and other reactive oxygen species (ROS) produced [1,2].
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The most used photosensitizers in PDT are porphyrins and related compounds [3].
Porphyrins bearing positively charged groups have proven to be superior photosensitizers
due to their interaction with specific cell structures, including with anionic DNA and RNA
[4–6]. Porphyrins bearing a variable number and type of cationic groups have been
successfully tested against cancer cells [5,7], keratinocytes [8], and microorganisms [9,10].
As was recently demonstrated by Slomp et al. [8], another benefit provided by cationic
porphyrins relates to their superior capacity for production of singlet oxygen in comparison
with their negatively charged or neutral analogs.
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Quaternary nitrogen-containing porphyrins, particularly those bearing different
combinations of N-methylated aminophenyl and pyridyl groups attached to the meso
positions, are by far the most explored examples of cationic photosensitizers [5]. The
literature shows that distinct cationic structures have improved PDI (Photodynamic
Inactivation) [11,12] or PDT efficacy; for example, the successful replacement of a methyl
group attached to the pyridyl nitrogen with long-chain alkyl groups [10,13] induces
increased efficacy. Furthermore, the presence of phenyl groups interleaved with the Nmethylpyridyl groups can result in porphyrins tending to form aggregates, which hinders
their photosensitizing properties. In this way, the search for alternative N-alkylation
methodologies that produce cationic porphyrin structures with different meso groups can be
an important tool for the development of efficient photosensitizers.
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In the present study, we have synthesized and examined the phototoxicity of new cationic
porphyrins. Specifically, the porphyrins herein evaluated possess two distinct structural
features of interest: the presence of (a) meso-dimethoxyphenyl instead of meso-phenyl
groups as a non-cationic appendage and (b) cationic nitrogens displaying the epoxymethyl
group. The former structural feature should prevent porphyrin aggregation behavior, while
the later could permit conjugation of porphyrins with specific biological ligands, such as
peptides, proteins, and carbohydrates [14,15].
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MATERIALS AND METHODS
Chemistry
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General.—Reagents and solvents were obtained from Sigma–Aldrich (St. Louis, MO) and
VWR International. Reactions were monitored by TLC using 0.2 mm silica plates. For
purification, column chromatography was performed using Sorbent Technologies 60 Å silica
gel (230–400 mesh) and preparative thin layer chromatography was performed using Merck
TLC silica gel 60 glass plates. The 1H NMR and 13C NMR spectra were obtained with a
Bruker AV-400 spectrometer (400 MHz for 1H, 100 MHz for 13C) with the indicated
solvents, and using TMS or residual solvent peaks as internal standards. Chemical shifts (d)
are expressed in parts per million (ppm) and coupling constants (J) in Hertz (Hz). Mass
spectra were obtained using an Agilent Technologies 6210 ESI-TOF. UV-Vis spectra were
measured using an Agilent Cary50 spectrometer using porphyrin concentrations of 1.2 ×
10−5 mol L −1 in CH2Cl2 or DMSO. Fluorescence emission spectra were collected using a
Perkin Elmer LS-55 spectrometer using porphyrin concentrations of 2 × 10 −6 mol L −1 in
DMSO. Melting points were obtained using a Barnstead Mel-Temp Electrothermal Model
1001 Capillary Melting Point Apparatus.
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Synthesis of 5,10,15-tri(3,5-dimethoxyphenyl)-20-(4-pyridyl) porphyrin (1).—
Porphyrin 1 was synthesized according to a methodology previously described [3] with
modifications. Pyrrole (780 μl, 12 mmol), 4-pyridinecarboxaldehyde (280 μl, 3 mmol), and
3,5-dimethoxybenzaldehyde (1.245 g, 9 mmol) were dissolved in 25 ml of propionic acid
and maintained in reflux for 3 hours. After this period, 25 ml of acetone were added and the
mixture filtered. Purification using silica gel column chromatography with chloroform/
methanol 98:2 for elution gave 25.0% yield of the title porphyrin. MP =>300°C. 1H NMR
(400 MHz, CDCl3) δ 8.95 (d, J = 5.14 Hz, 2H), 8.91 (d, J = 4.65 Hz, 2H), 8.87 (s, 4H), 8.70
(d, J = 4.65 Hz, 2H), 8.08 (d, J = 5.31 Hz, 2H), 7.31 (d,J = 1.99 Hz, 6H), 6.82 (s, 3H), 3.88
(s, 18H), −2.92 (s, 2H).13C NMR (100 MHz, CDCl3) δ 159.1, 150.6, 148.5, 144.0, 129.7,
120.7, 120.4, 116.5, 114.1, 100.3, 55.9, 31.3. UV-Vis (CH2Cl2) λmax (log ε) 420 (4.83), 513
(3.44), 549 (2.96), 588 (3.14), 644 (2.88) nm. MS (ESI) m/z calc. for [M + H]+,
C49H41N5O6+: 796.3129; Found: [M + H]+: 796.3116.
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Synthesis of 5-(4-dimethylaminophenyl)-10,15,20-triphenylporphyrin (2).—
Porphyrin 2 was synthesized as previously reported [16]. Briefly, pyrrole (173 μl, 2.49
mmol), 4-(dimethylamino)benzaldehyde (93 mg, 0.62 mmol) and benzaldehyde (190 μl,
1.90 mmol) were dissolved in 250 ml of dichloromethane, then trifluoroacetic acid (963 μl)
was added, and the solution was stirred for 20 min at room temperature. p-Chloranil (490
mg) was added and the mixture was maintained at 45°C for 1 hour. Triethylamine (1.74 ml)
was then added and the solution was concentrated. Purification using silica column
chromatography with dichloromethane/hexane 2:1 for elution gave the title porphyrin in
42.3% yield. The spectroscopic data were in agreement with the previous literature [16,17].
Synthesis of 5-(1-methylpyridinium-4-yl)-10,15,20-tri(3,5-dimethoxyphenyl)
porphyrin (3) and 5-(N,N, N-trimethyl-4-ammoniumphenyl)-10,15,20-triphenyl
porphyrin (4).—Methylation was performed following the literature, with some
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modifications [18]. 20 mg of porphyrin 1 (0.025 mmol) or 2 (0.03 mmol) and methyl iodide
(1 ml, 16 mmol) were added to 5 ml of DMF. The reaction was stirred for 5 hours at 45°C.
Dichloromethane (25 ml) was added and the organic solution was washed with water and
brine. The organic layer was dried over Na2SO4 and evaporated. Purification by
recrystallization using CH2Cl2/Et2O gave 91% yield for 3 and 86% yield for 4. Data for
porphyrin 4 is in agreement with literature [5,18]. Data for 3: MP = >300°C. 1H NMR (400
MHz, DMSOd) δ 9.44 (d, J = 6.68 Hz, 2H), 9.05 (d, J = 4.60 Hz, 2H), 8.98 (m, 8H), 7.38 (d,
J = 2.21 Hz, 6H), 7.02 (dd, J = 2.20 Hz, J1 = 4.62 Hz, 3H), 4.70 (2, 3H), 3.94 (s, 18H), −2.96
(s, 2H) 13C NMR (100 MHz, DMSOd) δ 158.7, 157.5, 143.9, 142.7, 132.2, 121.1, 120.45,
113.6, 113.0, 100.0, 55.5, 47.7, 30.6, 29.7. UV-Vis (DMSO) λmax (log ε) 425 (4.98), 516
(3.77), 553 (3.35), 589 (3.39), 645 (3.19) nm. MS (ESI) m/z calc. for [M]+, C50H44N5O6:
810.3280; Found: [M]+: 810.3293.
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Synthesis of 5-(1-epoxymethylpyridinium-4-yl)-10,15,20-tri(3,5dimethoxyphenyl) porphyrin (5) and 5-(N-dimethylepoxymethyl-4aminiumphenyl)-10,15,20-triphenyl porphyrin (6).—Alkylation was performed by
adding 20 mg of porphyrin 1 (0.025 mmol) or 2 (0.03 mmol) and epibromohydrin (2 ml,
23.37 mmol) to 5 ml of acetone. The reaction was maintained under reflux for 8 hours. After
drying under vacuum, the residue was purified by prep-TLC plates using the solvent system
chloroform/methanol/water (6:4:1). The yield obtained was 17% for 5 and 9% for 6. Data
for 5: MP = >3008C. 1H NMR(400 MHz, DMSOd) δ 9.45 (d, J = 6.21 Hz, 2H), 9.04–8.95
(m, 10H), 7.38 (d, J = 1.94 Hz, 6H), 7.01 (m, 3H), 6.45 (d,J = 4.35 Hz, 1H), 5.20 (d, J =
12.57 Hz, 1H), 4.84 (m, 1H), 4.55 (s, 1H), 3.93 (s, 18H), 3.82(dd, J = 6.03 Hz, J1 =10.46 Hz,
1H), −2.96 (s, 2H). 13C NMR (100 MHz, DMSO) δ 158.9, 148.8, 142.7, 132.2, 120.4,
113.6, 112.8, 100.0, 72.4, 70.8, 63.3, 63.0, 62.7, 59.5, 55.4, 37.1, 28.8. UV-Vis (DMSO)
λmax (log ε) 424 (4.73), 516 (3.54), 555 (3.21), 589 (3.25), 644 (3.07) nm. MS (ESI) m/z
calc. for [M]+, C52H46N5O7:852.3386; Found: [M]+: 852.3392. Data for 6: MP = >300°-C.
1H NMR (400 MHz, DMSO ) δ 8.84 (m, 8H), 8.51 (d, J = 8.82 Hz, 2H), 8.42 (d, J = 8.82
d
Hz, 2H), 8.22 (d, J = 6.71Hz, 6H), 7.84 (m, 9H), 5.13 (m, 1H), 4.71 (s, 1H), 4.14 (s, 1H),
3.92 (s, 6H), 3.62 (m, 2H), −2.92 (s, 2H). 13C NMR (100 MHz, DMSO) δ 206.4, 141.1,
135.3, 134.3, 127.1, 120.3, 70.9, 63.4, 56.7, 37.2, 31.2, 30.62, 28.9. UV-Vis (DMSO) λmax
(log ε) 420 (5.05), 515 (3.68), 549 (3.39), 590 (3.30), 650 (3.40) nm. MS (ESI) m/z calc. for
[M]+,C49H40N5O: 714.3221; Found: [M]+: 714.3214.
Cellular studies
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General.—The human carcinoma HEp2 cells used in these studies were purchased from
ATCC. The culture medium and other reagents were purchased from Life Technologies
(Carlsbad, CA). The HEp2 cells were cultured in medium (DMEM:Advanced 1:1)
containing 10% FBS and 1% antibiotic (penicillin-streptomycin). 32 mM porphyrin stock
solutions were prepared by dissolving each porphyrin in 95% DMSO and 5% Cremophor
EL (as a non-ionic emulsifier). The working concentrations were obtained by diluting the
stock solution with growing medium.
Time-dependent cellular uptake.—The HEp2 cells were plated at 15,000 cells per well
in a Costar 96-well plate (BD biosciences) and grown overnight. The cells were treated by
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adding 100 μl/well of 10 μM working solution at different time periods of 0, 1, 2, 4, 8, and
24 hours. The loading medium was removed at the end of each treatment. The cells were
washed with 1X PBS, and solubilized by adding 0.25% Triton X–100 in 1X PBS. A
compound standard curve using 10, 5, 2.5, 1.25, 0.625, and 0.3125 μM concentrations was
obtained by diluting the stock solution with 0.25% Triton X–100 (Sigma–Aldrich) in 1X
PBS. A cell standard curve was obtained using 10,000, 20,000, 40,000, 60,000, 80,000, and
10,0000 cells per well. The cells were quantified using the CyQuant Cell Proliferation Assay
(Life Technologies). The values were determined using a FluoStar Optima micro-plate
reader (BMG LRBTEH), with wavelengths of 584/650 nm for the compounds and 485/520
nm for the cells. Cellular uptake is expressed in terms of pM/cell.
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Dark cytotoxicity.—The HEp2 cells were placed in a 96-well plate as above, with the
compound concentrations of 200, 100, 50, 25, 12.5, 6.25, and 0 μM (five repetitions for each
concentration) and incubated at 37°C. After 24 hours incubation, the compound was
removed by washing the cells with 1X PBS and replaced with medium containing 20% cell
titer blue (CellTiter-Blue® assay, Promega, Madison, WI). The cells were incubated for an
additional 4 hours at 37°C. A fluorescence-based assay was used for measuring the viable
cells at 570/615 nm with a FluoStar Optima micro-plate reader. The dark toxicity is
expressed in terms of the percentage of viable cells.
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Phototoxicity.—Porphyrin concentrations of 100, 50, 25, 12.5, 6.25, 3.125, and 0 μM were
used for the phototoxicity experiments. The HEp2 cells were placed in 96-well plates as
described above, and treated with the compounds for 24 hours at 37°C. After 24 hours
treatment, the loading medium was removed. The cells were washed once with 1X PBS, and
then refilled with fresh medium. The cells were exposed to approximately 1.5 J/cm2 light
dose. After exposure to light, the cells were returned to the incubator for 24 hours. After this
time, the medium was removed and replaced with medium containing 20% CellTiter-Blue®.
The cells were incubated for an additional 4 hours. A fluorescence-based assay was used for
measuring the viable cells at 570/615 nm with a FluoStar Optima microplate reader. The
phototoxicity is expressed in terms of the percentage of viable cells.
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Microscopy.—The subcellular localization of this series of compounds was investigated by
fluorescence microscopy upon exposure of HEp2 cells to each compound at a concentration
of 10 μM for 6 hours. The organelle trackers (Invitrogen, Carlsbad, CA) ER Tracker Blue/
White (100 nM), BODIPY C5 Ceramide (50 nM), MitoTracker Green (250 nM), and
LysoSensor Green (50 nM) were added to the cells half hour before imaging. The cells were
washed three times with PBS solution and the images obtained using a Leica DM6B upright
microscope equipped with a water immersion objective, and DAPI, GFP, and Texas Red
filter cubes (Chroma Technologies, Bellows Falls, VT).
Comparative singlet oxygen quantum yields.—A standard solution of methylene
blue (MB) was prepared at a concentration of 10 μM in DMSO. Each porphyrin was
dissolved in DMSO at a concentration of 10 μM. To each well of a 6-well plate was added 3
ml each of DMSO, porphyrin solution, and MB solution. To each well was then added 3 ml
of a 100 μM solution of DPBF in DMSO. The plate was irradiated with a light intensity of
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1.25 mW/cm2 for 1 hour, and UV-Vis absorption measurements were taken before
irradiation (t = 0) and at 15, 30, 45, and 60 minutes after irradiation. UV/Vis absorbance’s
were plotted versus time points to obtain a fitted curve for the blank, standard and each
sample. The slope of the curves was used to determine the quantum yield for each sample
using the following equation:
Φ x = ΦMB × S x /SMB

where Ф represents quantum yield, S represents the slope, and x and MB represent sample
and methylene blue, respectively.

RESULTS AND DISCUSSION
Author Manuscript

Chemistry
Compound 1, bearing one meso-pyridyl group, was synthesized in 25% yield by
cyclocondensation of pyrrole, 4-pyridinecarboxaldehyde, and 3,5-dimethoxybenzaldehyde,
using Adler-Longo conditions with some modifications. The reaction was successful in
terms of yield, compared with previously reported meso-pyridyl porphyrins [9,19,20]. This
might be due to the enhanced solubility of porphyrin 1 compared with the meso-phenyl
analogs, which facilitated its purification. Porphyrin 1 was then used as precursor for the
alkylation reactions to give its cationic derivatives 3 and 5 (Scheme 1).
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An attempt to synthesize compound 2 also using an Adler-Longo methodology was
performed; however, the yields obtained in this case were very low (0.47%). Therefore,
porphyrin 2 was synthesized by means of a one-pot, two-step methodology, as previously
reported [16]. The purification step was accomplished by silica gel column chromatography
using the solvent system dichloromethane/hexane 2:1, which resulted in a relatively high
yield (42.3%) compared with that reported in the literature (19.5%) [16]. The spectroscopic
characterization data for this porphyrin is in agreement with those previously reported
[16,17]. After purification and characterization, compound 2 was used as starting material
for the quaternization reactions (Scheme 2). Interestingly, porphyrin 2 showed significant
lower fluorescence intensity compared with porphyrin 1 (see Supplemental Information).
The first cationic derivatives were synthesized via a methylation reaction using an excess of
methyl iodide, in DMF, to give compounds 3 (91% yield) and 4 (86% yield). Methylation
reactions with pyridylporphyrins were reported with yields varying between 27% and 90%
[5,9,20–22]. Porphyrin 4, also previously reported, was obtained in 70% yield [5,18].
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Each of the precursor porphyrins (1 and 2) were subjected to an alkylation reaction using
epibromohydrin as the alkylating agent, to give compounds 5 (17% yield), and 6 (9% yield)
as cationic derivatives. These compounds bear an epoxide group, which gives the porphyrin
the potential capacity to subsequently link to other molecules [23–26].
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The time-dependent uptake of porphyrins 1–6 was evaluated at a concentration of 10 μM
over a period of 24 hours (Fig. 1). Porphyrins 3 and 4 were rapidly accumulated inside the
HEp2 cells in the first 4 hours, with compound 4 being slightly faster to accumulate, and
after that a plateau was reached. Compounds 3 and 4 correspond to the methylated
derivatives of porphyrins 1 and 2, respectively, with the cationic derivatives accumulating
four times more, at all time points investigated, in comparison with their synthetic
precursors. Porphyrin 2 and its epoxide derivative 6 accumulate in cells slightly more than
porphyrin 1 and its epoxide derivative 5. The following order of increasing uptake after 24
hours was determined: 3~4>>2>6~5>1. In general, as expected and previously reported
[7,22,27], the accumulation values were higher for the cationic derivatives, which is
probably due to the fact that cell membranes are negatively charged. It was also observed
that the cationic derivatives bearing the epoxymethyl group accumulated poorly in
comparison to the exclusively methylated porphyrins. This observation possibly reflects the
differences in the way that these porphyrins interact with cell membranes. The alkylating
properties of the epoxide group, present in porphyrins 5 and 6, could prevent their access to
intracellular targets due to their potential immobilization in media structures, for example by
reaction with proteins. It was previously reported that the epoxide group possesses the
reactivity that enables the coupling with nucleophilic sites at the protein surface [28,29].
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The subcellular sites of localization of the cationic porphyrins were investigated by
fluorescence microscopy. Organelle-specific fluorophores BODIPY Ceramide (Golgi),
LysoSensor Green (lysosomes), MitoTracker Green (mitochondria), and ER Tracker Blue/
White (ER) were used in the overlay experiments. The purple or yellow/orange colors in
Figures 2–5 indicate co-localization of porphyrin and organelle tracker, and the results are
summarized in Table 1. All porphyrins localized mainly in the cell lysosomes, Golgi, and
ER. In addition, porphyrins 4 and 6 were also found in mitochondria. All these organelles
are important PDT targets that can lead to cell death upon light irradiation due to
photodamage to anti-apoptotic Bcl-2 proteins and/or by direct organelle photodamage [30].
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Porphyrins 1–6 were also evaluated in terms of their cytotoxicity against human carcinoma
HEp2 cells using a Cell Titer Blue assay. This assay provides a simple, fast, sensitive and
accurate method for determination of cell viability based on the generation of a fluorescente
product (resazurin is reduced to resorufin), and it has been shown to correlate well with
other methods for measuring cell proliferation and cytotoxicity. In order to detect any lightindependent cytotoxicity, the dark toxicity was first assayed by examining cell toxicity after
incubation with increasing concentrations of the porphyrins in the absence of light. Results
shown in Figure 6 indicate low dark toxicities for all the porphyrins at concentrations up to
200 μM (LD50> 200 μM). Cationic porphyrins previously reported exhibited LD50 in the
dark varying between 25–445 μM in various cell lines [5,27,31,32].
The phototoxicity assay (Fig. 7) was performed by exposing the HEp2 cells to
approximately 1.5 J/cm2 of light dose, after incubating the cells with the compounds at
concentrations up to 100 μM. We determined the following order of decreasing
phototoxicity: 4>3>6>5>2~1 (Table 2). It was noticed that epoxymethyl-containing
compound 6, which did not shown an appreciable uptake value, displayed moderate
Lasers Surg Med. Author manuscript; available in PMC 2019 August 14.
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phototoxicty (LD50 38 μM). This result suggests that the extent of cellular uptake does not
necessarily correlate with the observed phototoxicity, and that other factors, including the
sites of intracellular localization, ability to produce ROS, and potential biomolecule targets,
determine the cytotoxicity of the compounds.
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The lack of a correlation between phototoxicity and the amount of porphyrin sequestered
within the cells has been previously reported [5,33]. This is explained by the fact that the
phototoxicity is highly dependent not only on the ability of the photosensitizer to accumulate
within cells, but also on its intracellular targets and ability to generate ROS and/or 1O2 upon
light activation. The singlet oxygen quantum yields were determined in DMSO for this
series of porphyrins (Table 2) by measuring the change in absorbance of 1,3diphenylisobenzofuran (DPBF), as previously reported [34]. Our results show that the
cationic porphyrins 3, 4, 5, and 6 are more efficient producers of singlet oxygen compared
with the neutral derivatives 1 and 2. Among the cationic derivatives, 3, 4, and 5 were the
most efficient singlet oxygen generators, with quantum yields in the range 0.52–0.61. These
results are in agreement with previous reports showing that cationic porphyrins have the
ability to generate 1O2 [35–37]. In the present study porphyrins 3 and 4 showed the highest
uptake, high singlet oxygen quantum yields, and also the highest phototoxicity. This
suggests that the phototoxicity observed for these porphyrins is in part due to their high
cellular uptake and to their ability to generate singlet oxygen. Compound 4 was found to be
the most phototoxic with a LD50 of 2.4 μM. Porphyrin 3 also showed high phototoxicity
with a LD50 of 7.4 μM. In agreement with this result, phototoxic cationic porphyrins are
reported to have LD50 values varying between 3–8 μM in human HEp2 cells with similar
light dose [5,27]. On the other hand, the cationic porphyrins 5 and 6 bearing one
epoxymethyl group, were found to be less phototoxic than their methylated derivatives, with
LD50 values of 100 and 38 μM, respectively, although they are still efficient singlet oxygen
generators, particularly 5. This might be due to their much lower uptake into cells, as shown
in Figure 1, and/or their reactivity toward nucleophiles. The neutral porphyrins 1 and 2
showed no phototoxicity up to the 100 μM concentration investigated, and displayed the
lowest singlet oxygen quantum yields.

CONCLUSIONS
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A series of four cationic porphyrins bearing one meso-pyridyl or quaternary ammonium
groups were synthesized and their biological properties in human HEp2 cells, were
compared with their neutral derivatives. All porphyrins were non-toxic in the dark (LD50 >
200 μM), and upon light irradiation, only the cationic derivatives were found to be
phototoxic. Among these, the 5-(4-trimethylammoniumphenyl)-10,15,20-triphenylporphyrin
4 was the most phototoxic (LD50 = 2.4 μM, 1.5 J/cm2) followed by the 5-(4methylpyridiniumphenyl)-10,15,20-tri(3,5-dimethoxyphenyl)porphyrin 3 (LD50= 7.4 μM,
1.5 J/cm2). The cationic porphyrins bearing one epoxymethyl group, 5 and 6, were less
phototoxic than their methylated derivatives (LD50 > 38 μM, 1.5 J/cm2), in part due to their
lower cellular uptake, potentially due to their higher reactivity compared with 3 and 4. The
cationic porphyrins were found to be more efficient singlet oxygen producers compared with
the neutral porphyrin derivatives, and localized mainly in the cell ER, Golgi and lysosomes.
Among the series evaluated, porphyrins 3 and 4 are the most promising candidates for PDT
Lasers Surg Med. Author manuscript; available in PMC 2019 August 14.
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applications, while porphyrins 5 and 6 have potential capacity to bioconjugate to other
molecules via the epoxymethyl group.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.

Time-dependent cellular uptake of porphyrins 1 ( ), 2 ( ), 3 ( ), 4 ( ), 5 ( ), and 6 ( ) at
10 μM by HEp2 cells.

Author Manuscript
Lasers Surg Med. Author manuscript; available in PMC 2019 August 14.

Carneiro et al.

Page 13

Author Manuscript
Author Manuscript
Author Manuscript

Fig. 2.
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Subcellular localization of porphyrin 3 in HEp2 cells at 10 μM for 6 hours. (a) Phase
contrast, (b) porphyrin 3, (c) ER Tracker Blue/White, (d) overlay of 3 and ER Tracker, (e)
BODIPY Ceramide, (f) overlay of 3 and BODIPY Ceramide, (g) MitoTracker Green, (h)
overlay of 3 and MitoTracker, (i) LysoSensor Green, and (j) overlay of 3 and LysoSensor
Green. Scale bar: 10 μm.
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Fig. 3.
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Subcellular localization of porphyrin 4 in HEp2 cells at 10 μM for 6 hours. (a) Phase
contrast, (b) porphyrin 4, (c) ER Tracker Blue/White, (d) overlay of 4 and ER Tracker, (e)
BODIPY Ceramide, (f) overlay of 4 and BODIPY Ceramide, (g) MitoTracker Green, (h)
overlay of 4 and MitoTracker, (i) LysoSensor Green, and (j) overlay of 4 and LysoSensor
Green. Scale bar: 10 μm.
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Fig. 4.
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Subcellular localization of porphyrin 5 in HEp2 cells at 10 μM for 6 hours. (a) Phase
contrast, (b) porphyrin 5, (c) ER Tracker Blue/White, (d) overlay of 5 and ER Tracker, (e)
BODIPY Ceramide, (f) overlay of 5 and BODIPY Ceramide, (g) MitoTracker Green, (h)
overlay of 5 and MitoTracker, (i) LysoSensor Green, and (j) overlay of 5 and LysoSensor
Green. Scale bar: 10 μm.
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Fig. 5.
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Subcellular localization of porphyrin 6 in HEp2 cells at 10 μM for 6 hours. (a) Phase
contrast, (b) porphyrin 6, (c) ER Tracker Blue/White, (d) overlay of 6 and ER Tracker, (e)
BODIPY Ceramide, (f) overlay of 6 and BODIPY Ceramide, (g) MitoTracker Green, (h)
overlay of 6 and MitoTracker, (i) LysoSensor Green, and (j) overlay of 6 and LysoSensor
Green. Scale bar: 10 μm.
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Fig. 6.

Darktoxicity of porphyrins 1 ( ), 2 ( ), 3 ( ), 4 ( ), 5 ( ), and 6 ( ) using HEp2 cells and
a Cell Titer Blue assay.
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Fig. 7.

Phototoxicity (1.5 J/cm2) of porphyrins 1 ( ), 2 ( ), 3 ( ), 4 ( ), 5 ( ), and 6 ( ) using
HEp2 cells and a Cell Titer Blue assay.
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Scheme 1.

Synthesis of porphyrins 1, 3, and 5.
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Scheme 2.

Synthesis of porphyrins 2, 4, and 6.
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Major (+++) and Minor (+) Subcellular Sites of Localization of Cationic Porphyrins in HEp2 Cells
Compound

ER

Golgi

Mitochondria

Lysosomes

3

+++

+++

−

+++

4

+++

+++

+

++

5

+++

+++

−

+++

6

++

+

+

+++
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Phototoxicity (LD50 μM)
>100
>100
7.4
2.4
100
38

>200
>200
>200
>200
>200
>200

1

2

3

4

5

6

Compound

Dark Cytotoxicity (LD50 μM)

0.35

0.59

0.52

0.61

0.20

0.20

Ф

0.142 ± 0.016

0.142 ± 0.091

3.90 ± 0.024

3.10 ± 0.052

0.326 ± 0.035

0.080 ± 0.002

Uptake at 2 h (10−3pM/cell)

0.252 ± 0.002

0.322 ± 0.012

5.29 ± 0.085

4.43 ± 0.093

0.710 ± 0.027

0.134 ± 0.007

Uptake at 4 h (pM/cell)

0.429 ± 0.004

0.403 ± 0.018

5.36 ± 0.072

5.45 ± 0.088

0.901 ± 0.053

0.210 ± 0.011

Uptake at 8 h (pM/cell)

1.06 ± 0.038

0.778 ± 0.023

5.40 ± 0.330

5.45 ± 0.076

1.170 ± 0.013

0.518 ± 0.011

Uptake at 24 h (pM/cell)

Cytotoxicity (Cell Titer Blue Assay, 1.5 J/cm2), Comparative Singlet Oxygen Quantum Yields (Relative to Methylene Blue), and Cellular Uptake at
Selected Times of Porphyrins 1–6 in Human HEp2 Cells
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